Interlaboratory agreement in the monitoring of unfractionated heparin using the anti-factor Xa-correlated activated partial thromboplastin time: reply to a rebuttal

被引：0
|
作者：
Cuker, A. [1 ]
Cines, D. B. [1 ,2 ]
Pollak, E. S. [2 ,3 ]
机构：
[1] Univ Penn, Dept Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA
[3] Childrens Hosp Philadelphia, Dept Pathol, Philadelphia, PA 19104 USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷 / 12期
关键词：
THERAPEUTIC RANGE; REAGENTS;
D O I：
10.1111/j.1538-7836.2009.03625.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2158 / 2159
页数：3
相关论文
共 50 条
  • [41] Activated Partial Thromboplastin Time Monitoring of Unfractionated Heparin Therapy: Issues and Recommendations
    Marlar, Richard A.
    Clement, Bernadette
    Gausman, Jana
    [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2017, 43 (03): : 253 - 260
  • [42] Xcitement for Xa: Clinical Nurse Specialist as Orchestrator for Implementation of an Organizational Transition From Partial Thromboplastin Time (PTT) to Anti-Factor Xa for Heparin Monitoring
    Howard, Molly
    [J]. CLINICAL NURSE SPECIALIST, 2015, 29 (02) : E38 - E38
  • [43] Antifactor Xa levels vs. activated partial thromboplastin time for monitoring unfractionated heparin. A pilot study
    Samuel, S.
    Allison, T. A.
    Sharaf, S.
    Yau, G.
    Ranjbar, G.
    Mckaig, N.
    Nguyen, A.
    Escobar, M.
    Choi, H. A.
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2016, 41 (05) : 499 - 502
  • [44] Anti-Factor Xa Assay Is a Superior Correlate of Heparin Dose Than Activated Partial Thromboplastin Time or Activated Clotting Time in Pediatric Extracorporeal Membrane Oxygenation
    Liveris, Anna
    Bello, Ricardo A.
    Friedmann, Patricia
    Duffy, Melissa A.
    Manwani, Deepa
    Killinger, James S.
    Rodriquez, Daniel
    Weinstein, Samuel
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2014, 15 (02) : E72 - E79
  • [45] Correlation of activated partial thromboplastin time versus anti-Xa levels for unfractionated heparin monitoring in postoperative pediatric liver transplant patients
    Brocks, Rebecca
    Lemoine, Caroline
    Brandt, Katherine
    Bhat, Rukhmi
    Superina, Riccardo
    [J]. PEDIATRIC TRANSPLANTATION, 2022, 26
  • [46] Comparison of Anti-Xa and Activated Partial Thromboplastin Time Monitoring for Heparin Dosing in Patients With Cirrhosis
    Fuentes, Amaris
    Gordon-Burroughs, Sherilyn
    Hall, Jeffrey B.
    Putney, David R.
    Monsour, Howard P., Jr.
    [J]. THERAPEUTIC DRUG MONITORING, 2015, 37 (01) : 40 - 44
  • [47] Activated Partial Thromboplastin Time and Anti-Xa Measurements in Heparin Monitoring: Biochemical Basis for Discordance
    Takemoto, Clifford M.
    Streiff, Michael B.
    Shermock, Kenneth M.
    Kraus, Peggy S.
    Chen, Junnan
    Jani, Jayesh
    Kickler, Thomas
    [J]. AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2013, 139 (04) : 450 - 456
  • [48] Determining Cause for Activated Partial Thromboplastin Time and Anti-Factor Xa Discordance in Mechanical Circulatory Support Patients on Heparin; Can Thromboelastogram Help?
    Volod, O.
    Lam, L.
    Robert, C.
    Moriguchi, J.
    Yur, J.
    Garcia, M.
    Zhou, J.
    Wilde, A.
    Czer, L.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S463 - S463
  • [49] Concordance of the activated partial thromboplastin time and the anti-activated factor X assay in monitoring unfractionated heparin therapy in critically ill patients
    Rettmann, JA
    Markowitz, BA
    Wilson, L
    Mayer, J
    Lehman, CM
    [J]. CHEST, 2004, 126 (04) : 875S - 876S
  • [50] Anti-Factor Xa-Based Monitoring of Unfractionated Heparin: Clinical Outcomes in a Pediatric Cohort
    Saini, Surbhi
    Folta, Ashley N.
    Harsh, Katherine L.
    Stanek, Joseph R.
    Dunn, Amy L.
    O'Brien, Sarah H.
    Kumar, Riten
    [J]. JOURNAL OF PEDIATRICS, 2019, 209 : 212 - +
12345